{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:25:42Z","timestamp":1783938342092,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1038\/s41375-025-02530-9","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T11:31:38Z","timestamp":1740051098000},"page":"844-853","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Distinct leukemogenic mechanism of acute promyelocytic leukemia based on genomic structure of PML::RAR\u03b1"],"prefix":"10.1038","volume":"39","author":[{"given":"Mariko","family":"Minami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teppei","family":"Sakoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gentaro","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Kochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1302-3511","authenticated-orcid":false,"given":"Kensuke","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Sugio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Jinnouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohta","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Kunisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7763-5723","authenticated-orcid":false,"given":"Koichi","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7721-1696","authenticated-orcid":false,"given":"Yoshikane","family":"Kikushige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"key":"2530_CR1","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/367645a0","volume":"367","author":"T Lapidot","year":"1994","unstructured":"Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994;367:645\u20138.","journal-title":"Nature"},{"key":"2530_CR2","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730\u20137.","journal-title":"Nat Med"},{"key":"2530_CR3","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1182\/blood-2016-10-696054","volume":"129","author":"D Thomas","year":"2017","unstructured":"Thomas D, Majeti R. Biology and relevance of human acute myeloid leukemia stem cells. Blood. 2017;129:1577\u201385.","journal-title":"Blood"},{"key":"2530_CR4","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1182\/blood.V89.2.376","volume":"89","author":"JL Grisolano","year":"1997","unstructured":"Grisolano JL, Wesselschmidt RL, Pelicci PG, Ley TJ. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences. Blood. 1997;89:376\u201387.","journal-title":"Blood"},{"key":"2530_CR5","doi-asserted-by":"publisher","first-page":"13306","DOI":"10.1073\/pnas.97.24.13306","volume":"97","author":"DB Zimonjic","year":"2000","unstructured":"Zimonjic DB, Pollock JL, Westervelt P, Popescu NC, Ley TJ. Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice. Proc Natl Acad Sci USA. 2000;97:13306\u201311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2530_CR6","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3324\/haematol.2016.153528","volume":"102","author":"AM Paczulla","year":"2017","unstructured":"Paczulla AM, Dirnhofer S, Konantz M, Medinger M, Salih HR, Rothfelder K, et al. Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice. Haematologica. 2017;102:854\u201364.","journal-title":"Haematologica"},{"key":"2530_CR7","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/nm.4103","volume":"22","author":"A Reinisch","year":"2016","unstructured":"Reinisch A, Thomas D, Corces MR, Zhang X, Gratzinger D, Hong WJ, et al. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells. Nat Med. 2016;22:812\u201321.","journal-title":"Nat Med"},{"key":"2530_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03604-z","volume":"12","author":"DA Pereira-Martins","year":"2021","unstructured":"Pereira-Martins DA, Weinhauser I, Coelho-Silva JL, Franca-Neto PL, Almeida LY, Bianco TM, et al. MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model. Cell Death Dis. 2021;12:371.","journal-title":"Cell Death Dis"},{"key":"2530_CR9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/sj.leu.2403234","volume":"18","author":"D Grimwade","year":"2004","unstructured":"Grimwade D, Enver T. Acute promyelocytic leukemia: where does it stem from? Leukemia. 2004;18:375\u201384.","journal-title":"Leukemia"},{"key":"2530_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0268-960X(02)00075-9","volume":"17","author":"AR Mistry","year":"2003","unstructured":"Mistry AR, Pedersen EW, Solomon E, Grimwade D. The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease. Blood Rev. 2003;17:71\u201397.","journal-title":"Blood Rev"},{"key":"2530_CR11","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ccell.2017.10.002","volume":"32","author":"H de The","year":"2017","unstructured":"de The H, Pandolfi PP, Chen Z. Acute Promyelocytic Leukemia: A Paradigm for Oncoprotein-Targeted Cure. Cancer cell. 2017;32:552\u201360.","journal-title":"Cancer cell"},{"key":"2530_CR12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nrc2943","volume":"10","author":"H de The","year":"2010","unstructured":"de The H, Chen Z. Acute promyelocytic leukaemia: novel insights into the mechanisms of cure. Nat Rev Cancer. 2010;10:775\u201383.","journal-title":"Nat Rev Cancer"},{"key":"2530_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1300874","volume":"369","author":"F Lo-Coco","year":"2013","unstructured":"Lo-Coco F, Avvisati G, Vignetti M, Thiede C, Orlando SM, Iacobelli S, et al. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med. 2013;369:111\u201321.","journal-title":"N Engl J Med"},{"key":"2530_CR14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1200\/JCO.2016.67.1982","volume":"35","author":"U Platzbecker","year":"2017","unstructured":"Platzbecker U, Avvisati G, Cicconi L, Thiede C, Paoloni F, Vignetti M, et al. Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial. J Clin Oncol. 2017;35:605\u201312.","journal-title":"J Clin Oncol"},{"key":"2530_CR15","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0140-6736(77)91415-5","volume":"1","author":"JD Rowley","year":"1977","unstructured":"Rowley JD, Golomb HM, Dougherty C. 15\/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia. Lancet (Lond, Engl). 1977;1:549\u201350.","journal-title":"Lancet (Lond, Engl)"},{"key":"2530_CR16","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/0092-8674(91)90113-D","volume":"66","author":"H de The","year":"1991","unstructured":"de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell. 1991;66:675\u201384.","journal-title":"Cell"},{"key":"2530_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ccr.2009.12.042","volume":"17","author":"JH Martens","year":"2010","unstructured":"Martens JH, Brinkman AB, Simmer F, Francoijs KJ, Nebbioso A, Ferrara F, et al. PML-RARalpha\/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia. Cancer Cell. 2010;17:173\u201385.","journal-title":"Cancer Cell"},{"key":"2530_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ccr.2009.12.045","volume":"17","author":"K Wang","year":"2010","unstructured":"Wang K, Wang P, Shi J, Zhu X, He M, Jia X, et al. PML\/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia. Cancer cell. 2010;17:186\u201397.","journal-title":"Cancer cell"},{"key":"2530_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1182\/blood.V83.1.10.10","volume":"83","author":"F Grignani","year":"1994","unstructured":"Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, et al. Acute promyelocytic leukemia: from genetics to treatment. Blood. 1994;83:10\u201325.","journal-title":"Blood"},{"key":"2530_CR20","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1002\/j.1460-2075.1992.tb05185.x","volume":"11","author":"PP Pandolfi","year":"1992","unstructured":"Pandolfi PP, Alcalay M, Fagioli M, Zangrilli D, Mencarelli A, Diverio D, et al. Genomic variability and alternative splicing generate multiple PML\/RAR alpha transcripts that encode aberrant PML proteins and PML\/RAR alpha isoforms in acute promyelocytic leukaemia. EMBO J. 1992;11:1397\u2013407.","journal-title":"EMBO J"},{"key":"2530_CR21","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1182\/blood.V84.11.3843.bloodjournal84113843","volume":"84","author":"L Vahdat","year":"1994","unstructured":"Vahdat L, Maslak P, Miller WH Jr., Eardley A, Heller G, Scheinberg DA, et al. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN\/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid. Blood. 1994;84:3843\u20139.","journal-title":"Blood"},{"key":"2530_CR22","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.leukres.2015.05.016","volume":"39","author":"Y Lou","year":"2015","unstructured":"Lou Y, Ma Y, Suo S, Ni W, Wang Y, Pan H, et al. Prognostic factors of patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide-based frontline therapy. Leuk Res. 2015;39:938\u201344.","journal-title":"Leuk Res"},{"key":"2530_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2199-11-89","volume":"11","author":"A Jul-Larsen","year":"2010","unstructured":"Jul-Larsen A, Grudic A, Bjerkvig R, Boe SO. Subcellular distribution of nuclear import-defective isoforms of the promyelocytic leukemia protein. BMC Mol Biol. 2010;11:89.","journal-title":"BMC Mol Biol"},{"key":"2530_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/bjh.12362","volume":"162","author":"Y Tan","year":"2013","unstructured":"Tan Y, Bian S, Xu Z, Chen X, Qi X, Ren F, et al. The short isoform of the long-type PML-RARA fusion gene in acute promyelocytic leukaemia lacks sensitivity to all-trans-retinoic acid. Br J Haematol. 2013;162:93\u20137.","journal-title":"Br J Haematol"},{"key":"2530_CR25","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.stem.2010.11.014","volume":"7","author":"Y Kikushige","year":"2010","unstructured":"Kikushige Y, Shima T, Takayanagi S, Urata S, Miyamoto T, Iwasaki H, et al. TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells. cell stem cell. 2010;7:708\u201317.","journal-title":"cell stem cell"},{"key":"2530_CR26","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.stem.2015.07.011","volume":"17","author":"Y Kikushige","year":"2015","unstructured":"Kikushige Y, Miyamoto T, Yuda J, Jabbarzadeh-Tabrizi S, Shima T, Takayanagi S, et al. A TIM-3\/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression. cell stem cell. 2015;17:341\u201352.","journal-title":"cell stem cell"},{"key":"2530_CR27","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1182\/bloodadvances.2022008405","volume":"7","author":"T Sakoda","year":"2023","unstructured":"Sakoda T, Kikushige Y, Miyamoto T, Irifune H, Harada T, Hatakeyama K, et al. TIM-3 signaling hijacks the canonical Wnt\/\u03b2-catenin pathway to maintain cancer stemness in acute myeloid leukemia. Blood Adv. 2023;7:2053\u201365.","journal-title":"Blood Adv"},{"key":"2530_CR28","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1182\/blood-2008-12-196055","volume":"114","author":"G Yoshimoto","year":"2009","unstructured":"Yoshimoto G, Miyamoto T, Jabbarzadeh-Tabrizi S, Iino T, Rocnik JL, Kikushige Y, et al. FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation. Blood. 2009;114:5034\u201343.","journal-title":"Blood"},{"key":"2530_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinforma. 2013;14:128.","journal-title":"BMC Bioinforma"},{"key":"2530_CR30","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1111\/cas.13353","volume":"108","author":"J Yuda","year":"2017","unstructured":"Yuda J, Miyamoto T, Odawara J, Ohkawa Y, Semba Y, Hayashi M, et al. Persistent detection of alternatively spliced BCR-ABL variant results in a failure to achieve deep molecular response. Cancer Sci. 2017;108:2204\u201312.","journal-title":"Cancer Sci"},{"key":"2530_CR31","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1182\/blood.V88.5.1824.1824","volume":"88","author":"M Kizaki","year":"1996","unstructured":"Kizaki M, Matsushita H, Takayama N, Muto A, Ueno H, Awaya N, et al. Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid-resistant features. Blood. 1996;88:1824\u201333.","journal-title":"Blood"},{"key":"2530_CR32","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1182\/blood-2005-02-0516","volume":"106","author":"F Ishikawa","year":"2005","unstructured":"Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, et al. Development of functional human blood and immune systems in NOD\/SCID\/IL2 receptor {gamma} chain(null) mice. Blood. 2005;106:1565\u201373.","journal-title":"Blood"},{"key":"2530_CR33","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl. 2013;48:452\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"2530_CR34","doi-asserted-by":"publisher","first-page":"12133","DOI":"10.1073\/pnas.1412944111","volume":"111","author":"K Korf","year":"2014","unstructured":"Korf K, Wodrich H, Haschke A, Ocampo C, Harder L, Gieseke F, et al. The PML domain of PML-RARalpha blocks senescence to promote leukemia. Proc Natl Acad Sci USA. 2014;111:12133\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2530_CR35","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2530_CR36","first-page":"421","volume":"3","author":"KH Bi","year":"2006","unstructured":"Bi KH, Jiang GS. Relationship between cytokines and leukocytosis in patients with APL induced by all-trans retinoic acid or arsenic trioxide. Cell Mol Immunol. 2006;3:421\u20137.","journal-title":"Cell Mol Immunol"},{"key":"2530_CR37","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/nm.2415","volume":"17","author":"K Eppert","year":"2011","unstructured":"Eppert K, Takenaka K, Lechman ER, Waldron L, Nilsson B, van Galen P, et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med. 2011;17:1086\u201393.","journal-title":"Nat Med"},{"key":"2530_CR38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","volume":"12","author":"ED Lagadinou","year":"2013","unstructured":"Lagadinou ED, Sach A, Callahan K, Rossi RM, Neering SJ, Minhajuddin M, et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell. 2013;12:329\u201341.","journal-title":"Cell Stem Cell"},{"key":"2530_CR39","doi-asserted-by":"crossref","unstructured":"Le Cam L, Lacroix M, Ciemerych MA, Sardet C, Sicinski P. The E4F protein is required for mitotic progression during embryonic cell cycles. Mol Cell Biol. 2004;24:6467\u201375.","DOI":"10.1128\/MCB.24.14.6467-6475.2004"},{"key":"2530_CR40","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1101\/gad.1453406","volume":"20","author":"J Chagraoui","year":"2006","unstructured":"Chagraoui J, Niessen SL, Lessard J, Girard S, Coulombe P, Sauvageau M, et al. E4F1: a novel candidate factor for mediating BMI1 function in primitive hematopoietic cells. Genes Dev. 2006;20:2110\u201320.","journal-title":"Genes Dev"},{"key":"2530_CR41","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/ng1760","volume":"38","author":"YH Loh","year":"2006","unstructured":"Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, Chen X, et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet. 2006;38:431\u201340.","journal-title":"Nat Genet"},{"key":"2530_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62235-0","volume":"10","author":"P Verneri","year":"2020","unstructured":"Verneri P, Vazquez Echegaray C, Oses C, Stortz M, Guberman A, Levi V. Dynamical reorganization of the pluripotency transcription factors Oct4 and Sox2 during early differentiation of embryonic stem cells. Sci Rep. 2020;10:5195.","journal-title":"Sci Rep"},{"key":"2530_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.573915","volume":"11","author":"W Liao","year":"2020","unstructured":"Liao W, Du C, Wang J. The cGAS-STING Pathway in Hematopoiesis and Its Physiopathological Significance. Front Immunol. 2020;11:573915.","journal-title":"Front Immunol"},{"key":"2530_CR44","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s43018-024-00736-x","volume":"5","author":"H Dong","year":"2024","unstructured":"Dong H, He X, Zhang L, Chen W, Lin YC, Liu SB, et al. Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity. Nat Cancer. 2024;5:601\u201324.","journal-title":"Nat Cancer"},{"key":"2530_CR45","first-page":"311","volume":"91","author":"F Albano","year":"2006","unstructured":"Albano F, Mestice A, Pannunzio A, Lanza F, Martino B, Pastore D, et al. The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes. Haematologica. 2006;91:311\u20136.","journal-title":"Haematologica"},{"key":"2530_CR46","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1038\/leu.2009.143","volume":"23","author":"PV Sanchez","year":"2009","unstructured":"Sanchez PV, Perry RL, Sarry JE, Perl AE, Murphy K, Swider CR, et al. A robust xenotransplantation model for acute myeloid leukemia. Leukemia. 2009;23:2109\u201317.","journal-title":"Leukemia"},{"key":"2530_CR47","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.stem.2014.02.006","volume":"14","author":"A Kreso","year":"2014","unstructured":"Kreso A, Dick JE. Evolution of the cancer stem cell model. Cell Stem Cell. 2014;14:275\u201391.","journal-title":"Cell Stem Cell"},{"key":"2530_CR48","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1182\/blood.V85.8.2154.bloodjournal8582154","volume":"85","author":"AG Turhan","year":"1995","unstructured":"Turhan AG, Lemoine FM, Debert C, Bonnet ML, Baillou C, Picard F, et al. Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia. Blood. 1995;85:2154\u201361.","journal-title":"Blood"},{"key":"2530_CR49","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1046\/j.1365-2141.1998.00959.x","volume":"103","author":"T Haferlach","year":"1998","unstructured":"Haferlach T, Loffler H, Nickenig C, Ramm-Petersen L, Meeder M, Schoch R, et al. Cell lineage specific involvement in acute promyelocytic leukaemia (APL) using a combination of May-Grunwald-Giemsa staining and fluorescence in situ hybridization techniques for the detection of the translocation t(15;17)(q22;q12). Br J Haematol. 1998;103:93\u20139.","journal-title":"Br J Haematol"},{"key":"2530_CR50","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/ajcp\/112.6.819","volume":"112","author":"RH Edwards","year":"1999","unstructured":"Edwards RH, Wasik MA, Finan J, Rodriguez R, Moore J, Kamoun M, et al. Evidence for early hematopoietic progenitor cell involvement in acute promyelocytic leukemia. Am J Clin Pathol. 1999;112:819\u201327.","journal-title":"Am J Clin Pathol"},{"key":"2530_CR51","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1182\/blood-2017-07-794784","volume":"131","author":"E Voisset","year":"2018","unstructured":"Voisset E, Moravcsik E, Stratford EW, Jaye A, Palgrave CJ, Hills RK, et al. Pml nuclear body disruption cooperates in APL pathogenesis and impairs DNA damage repair pathways in mice. Blood. 2018;131:636\u201348.","journal-title":"Blood"},{"key":"2530_CR52","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/nrm2277","volume":"8","author":"R Bernardi","year":"2007","unstructured":"Bernardi R, Pandolfi PP. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol cell Biol. 2007;8:1006\u201316.","journal-title":"Nat Rev Mol cell Biol"},{"key":"2530_CR53","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13578-018-0204-8","volume":"8","author":"KS Hsu","year":"2018","unstructured":"Hsu KS, Kao HY. PML: Regulation and multifaceted function beyond tumor suppression. Cell Biosci. 2018;8:5.","journal-title":"Cell Biosci"},{"key":"2530_CR54","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s12185-014-1518-x","volume":"100","author":"F Nakahara","year":"2014","unstructured":"Nakahara F, Weiss CN, Ito K. The role of PML in hematopoietic and leukemic stem cell maintenance. Int J Hematol. 2014;100:18\u201326.","journal-title":"Int J Hematol"},{"key":"2530_CR55","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/nature07016","volume":"453","author":"K Ito","year":"2008","unstructured":"Ito K, Bernardi R, Morotti A, Matsuoka S, Saglio G, Ikeda Y, et al. PML targeting eradicates quiescent leukaemia-initiating cells. Nature. 2008;453:1072\u20138.","journal-title":"Nature"},{"key":"2530_CR56","doi-asserted-by":"publisher","first-page":"37300","DOI":"10.18632\/oncotarget.5836","volume":"6","author":"W Zhou","year":"2015","unstructured":"Zhou W, Cheng L, Shi Y, Ke SQ, Huang Z, Fang X, et al. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth. Oncotarget. 2015;6:37300\u201315.","journal-title":"Oncotarget"},{"key":"2530_CR57","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1172\/JCI62129","volume":"122","author":"A Carracedo","year":"2012","unstructured":"Carracedo A, Weiss D, Leliaert AK, Bhasin M, de Boer VC, Laurent G, et al. A metabolic prosurvival role for PML in breast cancer. J Clin Invest. 2012;122:3088\u2013100.","journal-title":"J Clin Invest"},{"key":"2530_CR58","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/stem.623","volume":"29","author":"YS Chuang","year":"2011","unstructured":"Chuang YS, Huang WH, Park SW, Persaud SD, Hung CH, Ho PC, et al. Promyelocytic leukemia protein in retinoic acid-induced chromatin remodeling of Oct4 gene promoter. Stem Cells. 2011;29:660\u20139.","journal-title":"Stem Cells"},{"key":"2530_CR59","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.4161\/auto.7.12.17991","volume":"7","author":"E Hatchi","year":"2011","unstructured":"Hatchi E, Rodier G, Sardet C, Le Cam L. E4F1 dysfunction results in autophagic cell death in myeloid leukemic cells. Autophagy. 2011;7:1566\u20137.","journal-title":"Autophagy"},{"key":"2530_CR60","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature20598","volume":"540","author":"SW Ng","year":"2016","unstructured":"Ng SW, Mitchell A, Kennedy JA, Chen WC, McLeod J, Ibrahimova N, et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature. 2016;540:433\u20137.","journal-title":"Nature"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02530-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02530-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02530-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T16:44:56Z","timestamp":1744217096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02530-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["2530"],"URL":"https:\/\/doi.org\/10.1038\/s41375-025-02530-9","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"16 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from all patients in accordance with the Helsinki Declaration of 1975, revised in 1983. All mouse experiments were conducted in accordance with guidelines approved by the Kyushu University Animal Care Committee. The animal experiment plan for this study has been approved in Kyushu University (A23-291-0).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}